The US Food and Drug Administration (FDA) said it is appropriate to use placebo arms in clinical trials when developing drugs to treat endogenous Cushing’s syndrome, despite ethical concerns raised by ...

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

A new draft guidance document issued by US regulators looks to expedite and facilitate the clinical development of drug therapies intended to treat community-acquired bacterial pneumonia (CABP). FDA ...

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The cutaneous T-cell lymphoma clinical trial analysis ...

When researchers are making a new drug, they face years of work in development and trials. Then, in about 90 per cent of cases, the outcome is a failure and they slide back, snakes-and-ladders style, ...

Thousands of proteins are known to cause disease, but while the biological activity of these proteins is understood, the way to hit and modulate them with a drug is not. Nature still has ways to bind ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

A partnership between the state of South Carolina, homegrown companies and Medical University of South Carolina is developing a drug to battle COVID-19 and possibly other viral infections. The state ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...